Effects of insulin infusion volume on diabetic ketoacidosis outcome in pediatrics: Retrospective observational study

Hessa Al Muqati1, Abeer Alsmari1,2,3, Mohanned Alrahili4

  • 1Pharmaceutical Care Services, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia.

Medicine
|May 12, 2025
PubMed

Insights

Changing insulin concentrations in diabetic ketoacidosis (DKA) treatment did not significantly impact hyperchloremic metabolic acidosis (HMA) incidence in pediatric patients. Further research is needed to optimize DKA management and prevent complications in diabetic children.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Metabolic Disorders

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication in pediatric diabetes.
  • Current DKA management often uses normal saline, potentially leading to hyperchloremia.
  • Optimizing insulin infusion strategies is crucial for preventing DKA-related complications.

Purpose of the Study:

  • To compare the incidence of hyperchloremic metabolic acidosis (HMA) between two insulin concentrations during DKA treatment.
  • To evaluate the impact of insulin concentration on chloride load and hospital stay in pediatric DKA patients.

Main Methods:

  • Retrospective observational study of 279 pediatric DKA admissions (January 2018 - June 2023).
  • Comparison of preprotocol (1 unit/10 mL) and postprotocol (1 unit/1 mL) insulin concentrations.
  • Analysis of demographics, DKA severity, electrolytes, fluid administration, chloride load, and length of stay.

Main Results:

  • No statistically significant difference in HMA incidence between preprotocol (43%) and postprotocol (38%) groups (P=.365).
  • Total chloride load per kg and length of hospital stay also showed no significant differences between the groups.
  • The postprotocol group had a higher incidence of new-onset type 1 diabetes cases.

Conclusions:

  • The concentration of insulin used in DKA management did not significantly affect the incidence of HMA.
  • Current findings suggest that changes in insulin concentration alone may not be sufficient to mitigate HMA in pediatric DKA.
  • Further investigation into fluid management and electrolyte balance is warranted for pediatric DKA treatment optimization.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
129
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
143
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K